Conversely, high-grade neuroendocrine carcinomas—such as SCLC and LCNEC—are characterized by frequent genetic alterations in TP53 and RB1, extensive genomic instability, and aggressive proliferation. The gene discussed is RB1; the disease is neuroendocrine carcinoma.